Extended Data Table 1 Summary of patients treated in the DBTP by genotype

From: Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial

  1. APOA5, gene encoding apolipoprotein A5; APOC2, gene encoding apolipoprotein C2; GPIHBP1, gene encoding glycosylphosphatidylinositol anchored high-density lipoprotein binding protein 1; IV, intravenous; LMF1, gene encoding lipase maturation factor 1; LPL, lipoprotein lipase; Q4W, every 4 weeks.
Back to article page